Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations

2016214 citationsJournal Article

Authors

Laurence Albigès · Xi'an Railway Survey and Design Institute

A. Ari Hakimi · Xi'an Railway Survey and Design Institute

Wanling Xie · Xi'an Railway Survey and Design Institute

Rana R. McKay · Xi'an Railway Survey and Design Institute

Ronit Simantov · Xi'an Railway Survey and Design Institute

Xun Lin · Xi'an Railway Survey and Design Institute

Jae‐Lyun Lee

Abstract

High BMI is a prognostic factor for improved survival and progression-free survival in patients with metastatic RCC treated with targeted therapy. Underlying biology suggests a role for the FASN pathway.

Topics & Keywords

Cancer, Lipids, and Metabolism Renal cell carcinoma treatment Ferroptosis and cancer prognosis

UN Sustainable Development Goals

No poverty

Publication Details

Published in: Journal of Clinical Oncology

Volume 34, Issue 30, pp. 3655-3663

DOI: 10.1200/jco.2016.66.7311

Field-Weighted Citation Impact: 7.72